HCVTX | OCGCX | HCVTX / OCGCX | |
Total Expense Ratio | 0.75 | 1.44 | 52% |
Annual Report Gross Expense Ratio | 0.75 | 1.44 | 52% |
Fund Existence | 18 years | 28 years | - |
Gain YTD | -1.175 | -0.683 | 172% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 140M | 3.89B | 4% |
Annual Yield % from dividends | 2.74 | 2.88 | 95% |
Returns for 1 year | 6.56 | 3.89 | 169% |
Returns for 3 years | 9.24 | 2.10 | 439% |
Returns for 5 years | 20.04 | 11.31 | 177% |
Returns for 10 years | 31.53 | 10.87 | 290% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GQGPX | 16.04 | 0.22 | +1.39% |
GQG Partners Emerging Markets Equity Inv | |||
HSFNX | 23.38 | 0.24 | +1.04% |
Hennessy Small Cap Financial Investor | |||
BRSTX | 12.10 | 0.10 | +0.83% |
MFS Blended Research Small Cap Eq R3 | |||
FELCX | 47.62 | -0.49 | -1.02% |
Fidelity Advisor Semiconductors C | |||
HGHTX | 40.10 | -0.46 | -1.13% |
Hartford Healthcare R5 |